Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination: the ADVICE Trial

NCT01058980 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT01058980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01058980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination: the ADVICE Trial
Lead sponsor
Montreal Heart Institute
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2009
Completion date
December 31, 2013
Enrollment
550 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

dormant pulmonary vein conduction, paroxysmal atrial fibrillation, pulmonary vein isolation